Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +48.15%
#3 Velvet Velvet +34.29%
#4 Black Phoenix Black Phoenix +34.09%
#5 Cross Cross +30.50%
#6 Akedo Akedo +28.62%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.95%
#8 QANplatform QANplatform +14.38%
#9 Perle Perle +13.09%
#10 Bitway Bitway +12.53%
Coin of the day
Glidr Glidr
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Aravive, Inc. Aravive, Inc.

Aravive, Inc.

ARAV
Classificação em ações #38758
Aravive, Inc. is a clinical-stage biopharmaceutical company, based in Houston,... Aravive, Inc. is a clinical-stage biopharmaceutical company, based in Houston, Texas, dedicated to discovering and developing innovative treatments for life-threatening illnesses such as cancer and fibrosis. The company's primary therapeutic candidate, batiraxcept, is an ultrahigh-affinity decoy protein engineered to disrupt the GAS6-AXL signaling pathway. This drug is currently progressing through a Phase III clinical trial for platinum-resistant recurrent ovarian cancer, and is also being evaluated in Phase Ib/II studies for clear cell renal cell carcinoma and pancreatic adenocarcinoma. Aravive also has AVB-S6 in its pipeline, a soluble Fc-fusion protein aimed at blocking the activation of the same GAS6-AXL pathway. Beyond internal development, Aravive has forged strategic partnerships. This includes a collaboration with WuXi Biologics (Hong Kong) Limited to develop novel, high-affinity bispecific antibodies targeting cancer and fibrosis. Furthermore, a license agreement with 3D Medicines Inc. grants rights to develop and commercialize products featuring batiraxcept as the sole active ingredient for human oncological diseases across mainland China, Taiwan, Hong Kong, and Macau. Originally incorporated in 2008 as Versartis, Inc., the company adopted the name Aravive, Inc. in October 2018.
Preço da ação
$0.0401
Última sincronização: 2024-02-07
Valor de mercado
$818.60K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Aravive, Inc. (ARAV)

Categoria

Healthcare
Histórico de desdobramentos de ações de Aravive, Inc. (ARAV)
As ações Aravive, Inc. (símbolo: ARAV) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 14, 2026.
Uma ação ARAV comprada antes de Aug 14, 2026 equivaleria hoje a 0 ações ARAV.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE